| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.00092 | 1 |